Suze Orman Warns Americans Underestimate Critical Retirement Healthcare Cost Microsoft Signals 190 Billion Capital Spending Push for 2026 as Memory Prices Surge Anupam Rasayan India to Acquire Up to 742 Stake in Bliss GVS Pharma in Rs 1360 Crore Deal Trump Administration Awards 2 Billion in Quantum Computing Grants IBM Leads with New Subsidiary Anderon BP Ousts Chairman Albert Manifold Extending Boardroom Turmoil Loop Capital Initiates Coverage on American Express with Buy Rating Designates Stock as Top Pick VNDA Q1 2026 Earnings EPS Misses Estimates as Operating Costs Weigh on Results SYF Q1 2026 Earnings EPS Beats Estimates Stock Edges Lower FormFactor Inc Q1 2026 Earnings EPS Surges Past Estimates Sending Shares Higher Emerson Radio MSN Q1 2024 Earnings Loss of 003 per Share Triggers 20 Stock Surge CIEN Q1 2026 Earnings Solid EPS Beat Despite Revenue Caution Stock Edges Up DUO Q2 2021 Earnings Massive EPS Miss Sends Shares Lower McDonalds MCD Modestly Rises as Shares Hold Ground Near Key Support Apimeds Pharmaceuticals APUS Slides 423 Support Level in Focus Creative Global Technology Holdings CGTL Slides 8 as Selling Pressure Intensifies Near Key Support Ennis Inc EBF Edges Higher Amid Modest Gains Holds Above Key Support Medicinova Inc MNOV Edges Higher on Modest Volume Faces Key Resistance at 141 CHAT vs XLK Performance and Fee TradeOffs for Tech Investors BGS Q1 2026 Earnings Earnings Beat Estimates by 457 as Bottom Line Exceeds Expectations Invesco Advantage Municipal Income Trust II VKI Posts Modest Gain Navigating Yield Opportunities and Key Technical Levels JOE Q1 2026 Earnings EPS of 024 as Stock Edges Lower KRNT Q1 2026 Earnings Narrower Loss Surprises Shares Edge Higher ADSK Q1 2026 Earnings EPS Beats Estimates Stock Edges Lower Despite Strong Quarter Cytokinetics Q1 2026 Earnings Narrower Loss Than Expected as Pipeline Advances STRO Q1 2026 Earnings Narrowing Losses Beat Estimates Stock Gains 7 SoundThinking Inc SSTI Q1 2026 Earnings Significant EPS Miss Amidst Market Optimism BHVN Q1 2026 Earnings EPS Miss Signals Heavy RD Burn as PreRevenue Biotech Navigates Pipeline Progress